Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
カリウムチャンネルモジュレーターとしてのCBXカンナビノイド受容体モジュレーターの使用
Document Type and Number:
Japanese Patent JP2009534440
Kind Code:
A
Abstract:
The invention is directed to the use of at least one CBx modulator wherein the CBx modulator is selected from the group consisting of CB1 agonists; CB2 agonists; CB2 partial agonists; CB2 antagonists; CB2 inverse agonists; and dually acting compounds which are both a CB1 agonist and a CB2 agonist; and mixtures thereof, as KATP channel modulator for the prophylaxis, treatment, delayed progression, delayed onset and/or inhibition of a variety of disease conditions including obesity, diabetes mellitus, metabolic syndrome, syndrome X, insulinoma, familial hyperinsulemic hypoglycemia, male pattern baldness, detrusor hyperreactivity, asthma, neuroprotection, epilepsy, analgesia, cardioprotection, angina, cardioplegia, arrhythmia, coronary spasm, peripheral vascular disease, cerebral vasospasm, appetite regulation, neurodegeneration, pain - including neuropathic pain and chronic pain - and impotence in mammals and humans. The invention further relates to methods of treating, preventing, delaying progression of, delaying onset of and/or inhibiting a variety of disease conditions including obesity, diabetes mellitus, metabolic syndrome, syndrome X, insulinoma, familial hyperinsulemic hypoglycemia, male pattern baldness, detrusor hyperreactivity, asthma, neuroprotection, epilepsy, analgesia, cardioprotection, angina, cardioplegia, arrhythmia, coronary spasm, peripheral vascular disease, cerebral vasospasm, appetite regulation, neurodegeneration, pain - including neuropathic pain and chronic pain - and impotence in mammals and humans comprising administering to a subject in need thereof an effective amount of at least one CBx modulator having KATP channel modulating properties.

Inventors:
Jochen Antel
Peter-Colin Gregory
Josephus Hubertus Maria Lange
Michael Firunges
Dania Reiche
Application Number:
JP2009507043A
Publication Date:
September 24, 2009
Filing Date:
April 20, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Solvay Pharmaceuticals GmbH
International Classes:
A61K45/00; A61K31/05; A61K31/09; A61K31/10; A61K31/18; A61K31/352; A61K31/397; A61K31/404; A61K31/415; A61K31/4155; A61K31/4164; A61K31/4196; A61K31/422; A61K31/426; A61K31/4406; A61K31/4439; A61K31/454; A61K31/4545; A61K31/4704; A61K31/5025; A61K31/5377; A61K31/55; A61K31/557; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/06; A61P9/10; A61P9/12; A61P11/06; A61P15/10; A61P17/14; A61P19/06; A61P25/00; A61P25/04; A61P25/08; A61P35/00; A61P43/00; C07C43/23; C07C69/587; C07C313/04; C07C317/32; C07D205/06; C07D209/12; C07D231/06; C07D231/14; C07D233/64; C07D233/88; C07D233/90; C07D277/20; C07D277/56; C07D311/76; C07D401/04; C07D401/06; C07D401/12; C07D401/14; C07D403/04; C07D403/12; C07D405/12; C07D413/04; C07D487/14; C07D498/06
Attorney, Agent or Firm:
Toshio Yano
Toshiomi Yamazaki
Takuya Kuno
Hiroshi Sugimoto
Kimihiro Hoshi
Hiroyasu Ninomiya
Einzel Felix-Reinhard
Reinhard Einsel